Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is...
evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 13, 2023 9:47am
Biotechs scramble as AUS leads in Psychedelics
https://t.co/E5rsAMlwcV
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 12, 2023 11:29am
The Fast-Spreading New COVID-19 Subvariant XBB
#Bucillamine https://www.msn.com/en-ca/health/medical/the-fast-spreading-new-covid-19-subvariant-xbb-is-part-of-a-new-class-of-omicron/ar-AA133Y9C?ocid=msedgntp&cvid
...more
(876)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Feb 10, 2023 8:18am
We have a lot of things going on exciting
things that will move this share price IMO bigtime https://time.com/6253702/psychedelics-psilocybin-mdma-legalization/ It came as a surprise to many when, on Feb. 3, Australian regulators
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 09, 2023 6:33pm
Bivalent COVID Vaccines Perform Worse Against Variant !
#Bucillamine https://www.theepochtimes.com/health/bivalent-covid-vaccines-perform-worse-against-variant-now-dominant-in-united-states-studies_5040659.html?utm_source=partner&utm_campaign
...more
(876)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Feb 09, 2023 12:23pm
Just about ready to
go on boil ? It has to be very very close lots of support seems to have stopped buying after loading up and perched waiting for the go signs ???
(5)
•••
cool888
X
View Profile
View Bullboard History
Comment by
cool888
on Feb 09, 2023 10:42am
RE:Interesting Article !
Full article https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.investorvillage.com/groups.asp%3Fmb%3D19572%26mn%3D7038%26pt%3Dmsg%26mid%3D23894157&ved
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 09, 2023 9:53am
Interesting Article !
#Bucillamine https://t.co/CuQWIfJFqi
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Feb 07, 2023 10:56am
RE:RE:$PHRM - fyi ..
COOL DA-FOOL, what do you mean no control in type c, DUH!, they are the one providing answers to the fda questions, if rvv provide sh1ts!, they will get sh1t reply from fda, so rvv for the last
...more
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Feb 07, 2023 9:19am
RE:$PHRM - fyi ..
COOL DA- FOOL. You can pump sh1ts this thing, but this wont matter to rvv, all that matters is the type c, COOL DA-FOOL, that what you have to tell to mfrank, mess up the type c and this thing go
...more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 07, 2023 9:07am
$PHRM - fyi ..
https://ca.finance.yahoo.com/news/pharmather-submits-fda-meeting-package-125900274.html
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Feb 06, 2023 1:05pm
RE:$RVV - fyi !
COOL DA-FOOL, email rvv mgt and bug them not to mess up the type c, you can post anysh1t you want but it wont be any help unless rvv passed that type c. COOL- DA FOOL!
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 06, 2023 12:38pm
$RVV - fyi !
https://twitter.com/i/spaces/1mrGmkAMVEzxy
(876)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Feb 06, 2023 8:33am
Sounds like a solid move !!!
https://financialpost.com/globe-newswire/revive-therapeutics-secures-mdma-supply-from-pharmala-biotech-for-mdma-transdermal-patch-development
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 06, 2023 8:00am
New Press Release - PharmAla Named Exclusive MDMA Supplier to Revive Therapeutics
PharmAla Biotech will provide MDMA to Revive Therapeutics in their development of an MDMA Microneedle Patch VANCOUVER, British Columbia, Feb. 06, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce that it has signed on to act as exclusive...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 06, 2023 8:00am
New Press Release - Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development
TORONTO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >